Delivering cervical cancer screening during the COVID-19 emergency

BMJ Sex Reprod Health. 2021 Oct;47(4):296-299. doi: 10.1136/bmjsrh-2021-201099. Epub 2021 Apr 29.

Authors

Cecilia Acuti Martellucci¹, Margherita Morettini², Maria Elena Flacco³, Lamberto Manzoli³, Matthew Palmer⁴, Giusi Giacomini², Francesca Pasqualini²

Affiliations

¹ Department of Medical Sciences, University of Ferrara, Ferrara, Italy cecilia.martellucci@gmail.com.
² Department of Prevention, Oncologic Screening Unit, Health Agency of the Marche Region, Ancona, Italy.
³ Department of Medical Sciences, University of Ferrara, Ferrara, Italy.
⁴ Melbourne School of Population and Global Health, The University of Melbourne, Carlton, Victoria, Australia.

PMID: 33926910
DOI: 10.1136/bmjsrh-2021-201099

No abstract available

Keywords: COVID-19; early detection of cancer; health care economics and organizations.

MeSH terms

COVID-19*
Early Detection of Cancer
Female
Humans
Papillomavirus Infections*
SARS-CoV-2
Uterine Cervical Neoplasms* / diagnosis
Uterine Cervical Neoplasms* / epidemiology